Annovis Bio, Inc. Stock Analysis & AI Score
Annovis Bio, Inc. (ANVS) has an ST Score of 32.2 (C-), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $25.67 price target (+2321.7% upside).
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
AI Daily Briefing
Analysis by AIANVS Stock Price History
ANVS Technical Indicators
FMPEarnings Surprises
Analyst Forecast
Revenue Mix
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NYSE |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Analyst Price Target
ESG Score
ANVS Latest Stock News
ST Score
Annovis Bio, Inc. (ANVS) has an ST Score of 32.2 (C-), driven by its Forecast (A) and held back by its Profitability (F). Analysts rate it Buy with a $25.67 price target (+2321.7% upside).
- Strongest
- ForecastA
- Weakest
- ProfitabilityF
All factor grades
- ForecastA
- Financial StrengthC+
- ValuationC
- GrowthC-
- MomentumD-
- ProfitabilityF
- Piotroski1/9
Press Releases
Company Contact Details
ANVS stock: frequently asked questions
What is ANVS's ST Score?
Annovis Bio, Inc. (ANVS) has an ST Score of 32.2 (C-), on our 0–100 scale where higher is stronger. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is ANVS a buy, hold, or sell?
Analysts rate ANVS a Buy, with a price target of $25.67 (+2321.7% vs the current price). Our ST Score grades it C- (32.2/100). The ST Score is a data-driven signal, not a recommendation.
What are ANVS's factor grades?
Valuation C, Profitability F, Financial Strength C+, Momentum D-, Growth C-, Forecast A.
What is ANVS's valuation grade?
Annovis Bio, Inc. (ANVS) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is ANVS's growth grade?
Annovis Bio, Inc. (ANVS) earns a growth grade of C-, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is ANVS's profitability grade?
Annovis Bio, Inc. (ANVS) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is ANVS's financial strength grade?
Annovis Bio, Inc. (ANVS) earns a financial strength grade of C+, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is the analyst price target for ANVS?
The average analyst price target for Annovis Bio, Inc. (ANVS) is $25.67 from 9 analysts, which is +2321.7% versus the recent price of $1.06.
What is ANVS's Piotroski score?
Annovis Bio, Inc. (ANVS) has a Piotroski F-Score of 1 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.